Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

The US pharmaceutical industry was booming ... as well as the science-boosting competition of the cold war. As the barriers to entry in drug production were raised, a great deal of consolidation ...

Keytruda, a $30 billion-a-year immunotherapy juggernaut, is the bestselling drug in the pharma industry and has long ... it ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

The pandemic led to massive increases in research and development among pharmaceutical companies as they raced to discover ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

The pharma industry in India continues to grow rapidly ... Currently, there is a strong global competition to attract more and more foreign investments. All these countries recognize that global ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Our Pharmaceutical Management MBA curriculum is in sync with the rhythm of the industry, which means you'll enter the workforce with readily applicable knowledge taught to you by distinguished ...

Multinational pharmaceutical companies (MNCs) operating in China’s vaccine market face growing challenges as regulatory scrutiny, intensifying domestic competition, and shifting consumer ...